Frazier Life Sciences XI, L.P.
10% Owner
CIK: 1911592
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 1,749,192 | - | - | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 1,590,175 | - | - | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 1,189,940 | - | - | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 961,322 | - | - | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 16,250,000 | $0.00 | $0.00 | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 14,772,727 | $0.00 | $0.00 | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 11,054,544 | $0.00 | $0.00 | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | C | 8,930,685 | $0.00 | $0.00 | View Details Filing |
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | P | 588,235 | $17.00 | $9,999,995.00 | View Details Filing |